Jinshan Nie

444 citations
6 papers · 142 indexed · h-index 3
Topics
Pancreatitis Pathology and Treatment (2 papers)Pancreatic and Hepatic Oncology Research (1 paper)Diabetes and associated disorders (1 paper)
Partner nations
ChinaJapanSaudi Arabia

In The Last Decade

Jinshan Nie

5 papers receiving 142 citations

Peers

Jinshan Nie
Comparison fields: 5 of 58
  • Molecular Biology 52
  • Biophysics 47
  • Cancer Research 29
  • Surgery 23
  • Oncology 22
Replace Zifei Liu with:
Zifei Liu United States
Atsushi Goto Japan
Bhawana Singh United Kingdom
Yutao Lei China
Yuhui Pan China
Kyu Sang Han United States
Stephanie Strobl Austria
Cainan Luo China
Jordan Castle United States
Jinshan Nie relative to Zifei Liu United States Zifei Liu's profile →
Citations per field
00.5×1.5×
Zifei Liu · 1×
Citations per year

Countries citing papers authored by Jinshan Nie

Since Specialization
Citations

This map shows the geographic impact of Jinshan Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinshan Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinshan Nie more than expected).

Fields of papers citing papers by Jinshan Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinshan Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinshan Nie. The network helps show where Jinshan Nie may publish in the future.

Co-authorship network of co-authors of Jinshan Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Jinshan Nie. A scholar is included among the top collaborators of Jinshan Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinshan Nie. Jinshan Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2 85
3 35
4
[The expression of peripheral Th1 and Th17 cells in inflammatory bowel disease and its potential clinical value].
2
5 18
6
[Relationship between genetic polymorphism of MCP-1 and acute pancreatitis in Han population of Suzhou in China].
2

About Jinshan Nie

Jinshan Nie is a scholar working on Biophysics, Oncology and Analytical Chemistry, having authored 6 papers that have together received 142 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Biophysics (47 citations), Analytical Chemistry (22 citations) and Cancer Research (29 citations). Jinshan Nie has collaborated with scholars based in China, Japan and Saudi Arabia. Frequent co-authors include Hua Gao, Weichang Chen, Min Wang, Wei Su, Jianpeng Ao, Minbiao Ji, Lei Shu, Jie He, Hao Hu and Ping‐Hong Zhou. Their work appears in journals such as Nature Communications, World Journal of Gastroenterology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026